Valuation: Takeda Pharmaceutical Company Limited

Market Cap 8,467B 52.43B 45.86B 42.15B 39.29B 74.47B 4,994B 75.62B 502B 197B 2,458B 197B 193B P/E 2027 *
43.6x
P/E 2028 * 27.9x
Enterprise Value 12,352B 76.5B 66.91B 61.5B 57.33B 109B 7,286B 110B 732B 287B 3,587B 287B 281B EV / Sales 2027 *
2.67x
EV / Sales 2028 * 2.6x
Free-Float
99.25%
Yield 2027 *
3.81%
Yield 2028 * 3.89%
1 day+1.61%
1 week+5.35%
Current month+3.96%
1 month+10.49%
3 months-7.64%
6 months+10.84%
Current year+10.84%
1 week 5,100
Extreme 5100
5,515
1 month 4,896
Extreme 4896
5,515
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer - 24/06/2026
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
04-27Free

Executive/Senior Manager

64,988 0.0041%
04-27Free

Chief Executive Officer

323,248 0.0203%
04-27Free

Executive/Senior Manager

72,124 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
+1.61%+5.35%+20.70%+18.61% 52.5B
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
-0.26%+1.37%+31.00%+23.97% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.64%+4.54%+29.93%+53.87% 374.49B
Weighted average by Cap. +1.86%+5.43%+41.45%+82.07%

Financials

2027 *2028 *
Net sales 4,630B 28.68B 25.08B 23.05B 21.49B 40.73B 2,731B 41.36B 275B 107B 1,344B 108B 105B 4,701B 29.11B 25.46B 23.4B 21.82B 41.35B 2,773B 41.99B 279B 109B 1,365B 109B 107B
Net income 184B 1.14B 996M 916M 853M 1.62B 108B 1.64B 10.9B 4.27B 53.4B 4.28B 4.19B 309B 1.92B 1.68B 1.54B 1.44B 2.72B 182B 2.76B 18.34B 7.18B 89.81B 7.2B 7.04B
Net Debt 3,886B 24.06B 21.05B 19.35B 18.03B 34.18B 2,292B 34.71B 230B 90.18B 1,128B 90.4B 88.46B 3,750B 23.23B 20.32B 18.67B 17.41B 32.99B 2,212B 33.5B 222B 87.05B 1,089B 87.26B 85.38B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
03/07/26 ¥5,359.00 +1.61% 4,074,200
02/07/26 ¥5,274.00 +2.41% 3,538,100
01/07/26 ¥5,150.00 -0.10% 4,177,200
30/06/26 ¥5,155.00 -0.41% 4,329,100
29/06/26 ¥5,176.00 +1.75% 7,388,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,359.00JPY
Average target price
6,106.87JPY
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock